1. Home
  2. ARDX vs MLNK Comparison

ARDX vs MLNK Comparison

Compare ARDX & MLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • MLNK
  • Stock Information
  • Founded
  • ARDX 2007
  • MLNK 1998
  • Country
  • ARDX United States
  • MLNK United States
  • Employees
  • ARDX N/A
  • MLNK N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • MLNK Computer Software: Prepackaged Software
  • Sector
  • ARDX Health Care
  • MLNK Technology
  • Exchange
  • ARDX Nasdaq
  • MLNK Nasdaq
  • Market Cap
  • ARDX 1.3B
  • MLNK 1.5B
  • IPO Year
  • ARDX 2014
  • MLNK 2021
  • Fundamental
  • Price
  • ARDX $4.79
  • MLNK $18.78
  • Analyst Decision
  • ARDX Strong Buy
  • MLNK Hold
  • Analyst Count
  • ARDX 9
  • MLNK 7
  • Target Price
  • ARDX $10.61
  • MLNK $21.64
  • AVG Volume (30 Days)
  • ARDX 3.9M
  • MLNK 262.5K
  • Earning Date
  • ARDX 05-01-2025
  • MLNK 03-06-2025
  • Dividend Yield
  • ARDX N/A
  • MLNK N/A
  • EPS Growth
  • ARDX N/A
  • MLNK N/A
  • EPS
  • ARDX N/A
  • MLNK N/A
  • Revenue
  • ARDX $333,615,000.00
  • MLNK $316,298,000.00
  • Revenue This Year
  • ARDX $14.26
  • MLNK $7.59
  • Revenue Next Year
  • ARDX $32.49
  • MLNK $8.13
  • P/E Ratio
  • ARDX N/A
  • MLNK N/A
  • Revenue Growth
  • ARDX 168.06
  • MLNK 4.18
  • 52 Week Low
  • ARDX $4.32
  • MLNK $16.49
  • 52 Week High
  • ARDX $9.33
  • MLNK $25.33
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 37.46
  • MLNK 45.22
  • Support Level
  • ARDX $4.68
  • MLNK $18.24
  • Resistance Level
  • ARDX $5.56
  • MLNK $19.57
  • Average True Range (ATR)
  • ARDX 0.25
  • MLNK 0.42
  • MACD
  • ARDX -0.05
  • MLNK -0.07
  • Stochastic Oscillator
  • ARDX 12.71
  • MLNK 37.07

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About MLNK MeridianLink Inc.

MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.

Share on Social Networks: